TORONTO, July 24 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. is pleased to announce that the booked patient appointments for the summer quarter (July, August and September) is up 140% over the previous quarter.
"Considering we are in the height of vacation season, we are very pleased with this significant increase in patient booking." said Mr. Schiller, the President of Innolife Pharma Inc. "This only further serves as positive proof to the huge groundswell of chronic pain sufferers that are in dire need of this breakthrough non-narcotic treatment and our build out across North America of certified licensees will be in much demand."
Today, one in five Americans suffer with chronic pain (~ 60 million adults) spending approximately $120 Billion a year and the aging baby boomers have reported in surveys more aches and pains than any previous generation.
About Innolife Pharma Inc.
--------------------------
Innolife Pharma Inc. (PINKSHEETS: INNP) is a small publicly traded specialty multi-discipline medical group focusing on licensing the Natural Pain Relief Center all-non-narcotic proprietary breakthrough in the treatment of chronic pain.
FORWARD-LOOKING STATEMENTS:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
CONTACT: Innolife Pharma Inc., T (416) 849-2275, F (416) 840-8431, Email:
info@innolifepharma.com, www.innolifepharma.com